Relationship between health-related quality of life measures and high HIV viral load in HIV-infected triple-class-experienced patients [0.03%]
经三线治疗的HIV感染者健康相关生活质量量表与高病毒载量之间的关系
Raffaella Bucciardini,Katherina Pugliese,Liliana Weimer et al.
Raffaella Bucciardini et al.
Background: Health-related quality of life (HRQoL) has been recognized as a central measure of the overall health status in HIV patients. With the availability of different highly effective drug combinations, maximizing q...
Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trial [0.03%]
氟西汀预防艾滋病-丙型肝炎共感染初学者在接受长效干扰素/利巴韦林治疗时出现抑郁及其后果的多中心随机双盲安慰剂对照试验
Marina B Klein,Terry Lee,Marie-Josée Brouillette et al.
Marina B Klein et al.
Background: Depression related to interferon-alpha (IFN-α) is common, may reduce adherence, and can be treatment limiting. HIV-HCV coinfected persons experience lower sustained virologic response rates and commonly have ...
Randomized Controlled Trial
HIV clinical trials. 2014 Jul-Aug;15(4):161-75. DOI:10.1310/hct1504-161 2014
Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection: data from the ICONA foundation cohort [0.03%]
达芦那韦抗逆转录病毒治疗HIV-1感染患者ALT升高的危险因素：有或无丙型肝炎病毒感染者的依曲洛新基金会队列数据
Antonio Di Biagio,Laura Ambra Nicolini,Patrizia Lorenzini et al.
Antonio Di Biagio et al.
Objectives: To investigate differences in liver enzyme elevation (LEE) between HIV-infected patients with and without HCV coinfection who start a darunavir/ritonavir-containing regimen. ...
Multicenter Study
HIV clinical trials. 2014 Jul-Aug;15(4):151-60. DOI:10.1310/hct1504-151 2014
Efficacy and safety of darunavir/ritonavir plus etravirine dual regimen in antiretroviral therapy-experienced patients: a multicenter clinical experience [0.03%]
达芦那韦/利托那韦联合埃替拉韦二线治疗的疗效和安全性：多中心临床经验报告
Lidia Gazzola,Paola Cicconi,Diego Ripamonti et al.
Lidia Gazzola et al.
Objectives: To assess the outcome of a dual regimen combining darunavir/ritonavir plus etravirine in a cohort of antiretroviral therapy (ART)-experienced patients. ...
Observational Study
HIV clinical trials. 2014 Jul-Aug;15(4):140-50. DOI:10.1310/hct1504-140 2014
Clinical and immunologic predictors of death after an acute opportunistic infection: results from ACTG A5164 [0.03%]
急性机会性感染后的临床和免疫学死亡预测因素：ACTG A5164研究结果
Philip M Grant,Lauren Komarow,Alejandro Sanchez et al.
Philip M Grant et al.
Background: In the pre-antiretroviral therapy (ART) era, markers of increased disease severity during an acute opportunistic infection (OI) were associated with mortality. Even with ART, mortality remains high during the ...
Characteristics of persistent hyponatremia and tolvaptan treatment in nine hospitalized patients with advanced HIV disease [0.03%]
托伐普坦治疗9例晚期HIV感染住院患者的顽固性低钠血症的特征
Ying Wen,Ying Zhou,Wen Wang et al.
Ying Wen et al.
Factors associated with study attrition among HIV-infected risky drinkers in St. Petersburg, Russia [0.03%]
俄罗斯圣彼得堡HIV感染者中危险饮酒者研究脱落的相关因素
T Kiriazova,D M Cheng,S M Coleman et al.
T Kiriazova et al.
Background: Participant attrition in HIV longitudinal studies may introduce bias and diminish research quality. The identification of participant characteristics that are predictive of attrition might inform retention str...
Rate, predictors, and consequences of late antenatal booking in a national cohort study of pregnant women with HIV in Italy [0.03%]
意大利HIV阳性孕妇全国队列研究中晚期产前登记率、预测因素及后果
M Floridia,C Pinnetti,M Ravizza et al.
M Floridia et al.
Objective: To evaluate the prevalence and consequences of late antenatal booking (13 or more weeks gestation) in a national observational study of pregnant women with HIV. ...
Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone [0.03%]
初治患者接受阿扎那韦/利托那韦或依非韦伦联合固定复方背景治疗的病毒学和免疫学疗效比较研究
Qing Wang,Jim Young,Enos Bernasconi et al.
Qing Wang et al.
Background: Atazanavir boosted with ritonavir (ATV/r) and efavirenz (EFV) are both recommended as first-line therapies for HIV-infected patients. We compared the 2 therapies for virologic efficacy and immune recovery. ...
Observational Study
HIV clinical trials. 2014 May-Jun;15(3):92-103. DOI:10.1310/hct1503-92 2014
The problem of renal function monitoring in patients treated with the novel antiretroviral drugs [0.03%]
新型抗逆转录病毒药物治疗患者肾功能监测的问题
Paolo Maggi,Vincenzo Montinaro,Stefano Rusconi et al.
Paolo Maggi et al.
Chronic kidney disease (CKD) is currently considered a major comorbidity in patients affected by HIV infection. In addition, new generation antiretroviral drugs that interact with creatinine transporters were recently introduced. Rilpivirin...